Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estrogen replacement therapy, atherosclerosis, and vascular function.

Tomi S Mikkola1, Thomas B Clarkson

  • 1Comparative Medicine Clinical Research Center, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1040, USA.

Cardiovascular Research
|February 28, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vaginal use of estradiol is associated with a reduced risk of rectal cancer in postmenopausal women: A Finnish nationwide case-control study.

Maturitas·2025
Same author

Female Adipose Tissue Sex Steroid Biosynthesis.

Seminars in reproductive medicine·2025
Same author

Progestogens in Menopausal Hormone Therapy: A Double-Edged Sword.

Seminars in reproductive medicine·2025
Same author

Tension-Free Vaginal Tape versus Polyacrylamide Hydrogel Injection for Stress Urinary Incontinence - 5-Year Follow-Up.

NEJM evidence·2025
Same author

Tension-Free Vaginal Tape versus Polyacrylamide Hydrogel Bulking Agent for Stress Urinary Incontinence: Patient Choice and Outcomes in Finland.

International urogynecology journal·2025
Same author

Update of the impact of menopausal hormone therapy on breast cancer risk.

European journal of cancer (Oxford, England : 1990)·2025
Same journal

Metabolic crisis and TRPM4 activation cause QT prolongation in TANGO2 deficiency disorder.

Cardiovascular research·2026
Same journal

Personalizing Atrial Fibrillation Therapy: Moving from Genetic Association to Mechanistic Translation.

Cardiovascular research·2026
Same journal

Placental Growth Factor Promotes Endothelial Activation and Inflammatory Remodelling in Pulmonary Hypertension.

Cardiovascular research·2026
Same journal

Endothelial-to-mesenchymal transition (EndMT) in atherosclerosis: mechanisms, models and therapies.

Cardiovascular research·2026
Same journal

The gut-heart axis in cardio-oncology.

Cardiovascular research·2026
Same journal

Proteomic signatures as biomarkers of atherosclerosis burden.

Cardiovascular research·2026
See all related articles

Estrogen deficiency accelerates atherosclerosis, while estrogen replacement benefits younger women and monkeys in early stages. Progestogens show minimal impact on these cardiovascular benefits.

Area of Science:

  • Cardiovascular Science
  • Endocrinology
  • Women's Health

Background:

  • Estrogen deficiency is linked to increased atherosclerosis progression.
  • The role of postmenopausal estrogen replacement therapy (ERT) in inhibiting atherosclerosis is debated.
  • Previous studies show mixed results regarding ERT's cardiovascular benefits.

Purpose of the Study:

  • To evaluate the efficacy of estrogen replacement in preventing atherosclerosis progression.
  • To investigate the influence of progestogens on estrogen's cardiovascular benefits.
  • To address compliance issues with ERT due to breast cancer concerns.

Main Methods:

  • Analysis of human and nonhuman primate studies on estrogen and atherosclerosis.
  • Comparison of ERT effects in different age groups and stages of atherosclerosis.

Related Experiment Videos

  • Review of evidence regarding progestogen co-administration with estrogen.

    • Main Results:

    • Estrogen deficiency demonstrably increases atherosclerosis progression.
    • ERT showed significant benefits in younger postmenopausal women and early-stage atherosclerosis in monkeys.
    • Estrogen treatment in older women with existing coronary artery disease yielded no benefits.
    • Progestogens appear to have minimal to no negative impact on ERT's benefits for coronary artery atherosclerosis.

    Conclusions:

    • Estrogen replacement therapy is most effective in younger postmenopausal women or during early stages of atherosclerosis.
    • Progestogens do not significantly attenuate the cardiovascular benefits of estrogen.
    • Future ERT strategies may involve combining low-dose estrogen with breast cancer preventive agents to improve compliance.